Across a number of ARPKD kidneys taken from patients who had reached end stage renal disease aged 0–18 years, a significant 2-fold increase in ATMIN mRNA expression was consistently observed compared to normal paediatric kidneys (Fig. 7A, n = 11, p < 0.01). The gene discussed is ATMIN; the disease is stage 5 chronic kidney disease.